Helix Biotech Biosimilar mRNA Vaccines

{
  "awards": [
    {
      "id": "2",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Vaccines",
              "id": "33651600",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UK"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-PPON-PCMD-6995-GBGZ",
          "name": "Helix Biotech Inc."
        }
      ]
    }
  ],
  "buyer": {
    "id": "GB-PPON-PBMQ-7576-DVGW",
    "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
  },
  "contracts": [
    {
      "aboveThreshold": true,
      "agreedMetrics": [
        {
          "description": "Certificate of Analysis for each product produced",
          "id": "1",
          "observations": [
            {
              "id": "frequency",
              "period": {
                "durationInMonths": 12
              }
            }
          ],
          "title": "Certificate of Analysis"
        }
      ],
      "awardID": "2",
      "dateSigned": "2025-12-17T00:00:00Z",
      "documents": [
        {
          "datePublished": "2025-12-18T11:56:52Z",
          "description": "Contract details notice on Find a Tender",
          "documentType": "contractNotice",
          "format": "text/html",
          "id": "084284-2025",
          "noticeType": "UK7",
          "url": "https://www.find-tender.service.gov.uk/Notice/084284-2025"
        }
      ],
      "id": "2",
      "period": {
        "endDate": "2027-12-17T23:59:59Z",
        "startDate": "2025-12-18T00:00:00Z"
      },
      "status": "active",
      "title": "Helix Biotech Biosimilar mRNA Vaccines",
      "value": {
        "amount": 150000.0,
        "amountGross": 180000.0,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-12-18T11:56:52Z",
  "id": "084284-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-059422",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "E14 4PU",
        "region": "UKI42",
        "streetAddress": "10 South Colonnade"
      },
      "contactPoint": {
        "email": "commercial.preparednessandcountermeasures@ukhsa.gov.uk",
        "name": "Commercial Preparedness and Medical Countermeasures Team"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.gov.uk/government/organisations/uk-health-security-agency"
      },
      "id": "GB-PPON-PBMQ-7576-DVGW",
      "identifier": {
        "id": "PBMQ-7576-DVGW",
        "scheme": "GB-PPON"
      },
      "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "US",
        "countryName": "United States",
        "locality": "Knoxville",
        "postalCode": "37918",
        "region": "US",
        "streetAddress": "1460 Breda Drive"
      },
      "contactPoint": {
        "email": "info@helix-biotech.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-PPON-PCMD-6995-GBGZ",
      "identifier": {
        "id": "PCMD-6995-GBGZ",
        "scheme": "GB-PPON"
      },
      "name": "Helix Biotech Inc.",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C371747",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs). Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "status": "complete",
    "title": "Helix Biotech Biosimilar mRNA Vaccines"
  }
}